Education
About Us
Working with TipRanks
Follow Us
Tela Bio, Inc. (TELA)
:TELA
TELA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.86 - $4.30
Previous CloseN/A
Volume34.27K
Average Volume (3M)58.34K
Market Cap
$73.57M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.56
Next Earnings
Aug 11, 2025EPS Estimate
-0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.25
Shares Outstanding39,554,990
10 Day Avg. Volume60,968
30 Day Avg. Volume58,342
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$4.00Price Target Upside135.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Bulls Say, Bears Say
Bulls Say
Market PositionThe product portfolio and growth rate support the potential for multiple expansion, making the current valuation appear too low.
New Product LaunchesNew products like inguinal hernia and Liquifix have been successful since their launch, providing TELA opportunities in high-volume procedures.
Product PerformanceTELA's products are considered best-in-class, supported by strong clinical data and trends in robotic adoption.
Bears Say
Financial PerformanceTELA reported results significantly below estimates, with a significant sales force turnover impacting the company's performance.
Funding NeedsThe company may need another round of financing to fund operations, which could negatively impact the stock.
Sales Force TurnoverThe departure of 11 of 69 high-performing territory managers led to a significant drop in sales.
TELA Bio News
TELA FAQ
What was Tela Bio, Inc.’s price range in the past 12 months?
Tela Bio, Inc. lowest stock price was $0.86 and its highest was $4.30 in the past 12 months.
What is Tela Bio, Inc.’s market cap?
Tela Bio, Inc.’s market cap is $73.57M.
When is Tela Bio, Inc.’s upcoming earnings report date?
Tela Bio, Inc.’s upcoming earnings report date is Aug 11, 2025 which is in 8 days.
How were Tela Bio, Inc.’s earnings last quarter?
Tela Bio, Inc. released its earnings results on May 08, 2025. The company reported -$0.25 earnings per share for the quarter, missing the consensus estimate of -$0.196 by -$0.054.
Is Tela Bio, Inc. overvalued?
According to Wall Street analysts Tela Bio, Inc.’s price is currently Undervalued.
Does Tela Bio, Inc. pay dividends?
Tela Bio, Inc. does not currently pay dividends.
What is Tela Bio, Inc.’s EPS estimate?
Tela Bio, Inc.’s EPS estimate is -0.18.
How many shares outstanding does Tela Bio, Inc. have?
Tela Bio, Inc. has 39,554,990 shares outstanding.
What happened to Tela Bio, Inc.’s price movement after its last earnings report?
Tela Bio, Inc. reported an EPS of -$0.25 in its last earnings report, missing expectations of -$0.196. Following the earnings report the stock price went up 9.091%.
Which hedge fund is a major shareholder of Tela Bio, Inc.?
Currently, no hedge funds are holding shares in TELA
TELA Bio Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (135.29% Upside)
$4.00 (135.29% Upside)
Blogger Sentiment
Bullish
TELA Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 1.0M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 3.6%
Last 30 Days ▼ 3.8%
Last 30 Days ▼ 3.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.43%
12-Months-Change
Fundamentals
Return on Equity
-267.29%
Trailing 12-Months
Asset Growth
7.54%
Trailing 12-Months
Company Description
Tela Bio, Inc.
TELA Bio, Inc. is a medical technology company focused on the design, development, and commercialization of innovative tissue reinforcement materials. The company operates primarily in the healthcare sector, specializing in advanced surgical solutions. Its core products include the OviTex Reinforced Tissue Matrix, which is used in soft tissue reconstruction, and the OviTex PRS for plastic and reconstructive surgery. TELA Bio aims to improve patient outcomes through its proprietary technology that integrates biologic and synthetic materials.
TELA Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
TELA Bio's earnings call highlighted strong revenue growth and product demand, particularly in the European market, despite facing some challenges such as tariff impacts and increased net loss. The company's strategic organizational changes and innovative product launches position it well for future growth.Read More>TELA Stock 12 Month Forecast
Average Price Target
$4.00
▲(135.29%Upside)
Technical Analysis
Ownership Overview
13.14% Insiders
7.10% Mutual Funds
0.17% Other Institutional Investors
74.70% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---